$S2 Ep3: OncView™ Podcast: Management of Relapsed/Refractory Follicular Lymphoma$

Season 2 · Episode 3

S2 Ep3: OncView™ Podcast: Management of Relapsed/Refractory Follicular Lymphoma

June 17, 202129m 7s

Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Original episode page

Show Notes

As part of its OncView™ video series, CancerNetwork® spoke with Sameh Gaballa, MD, of the Moffit Cancer Center, about current and future treatment options, and considerations for patients with relapsed/refractory follicular lymphoma.

In the video series, Gaballa discussed the following:

· Treatment Options in Relapsed/Refractory Follicular Lymphoma

· Considerations for Treatment Selection in R/R FL

· Third-Line Therapy in Follicular Lymphoma

· Tazemetostat for Relapsed/Refractory Follicular Lymphoma

· R/R FL: The Role of PI3K Inhibitors

· Unmet Needs and Looking Ahead in Follicular Lymphoma

To watch more videos in CancerNetwork®’s OncView™ series, visit cancernetwork.com/oncview.

← All episodes of Oncology On The Go